Related Experiment Video
Updated: Jun 6, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
Published on: September 30, 2025
Low-density lipoprotein cholesterol target achievement in patients at high risk for coronary heart disease
Danai Kitkungvan1, Nicole M Lynn Fillipon, Sourbha S Dani
1Department of Medicine, Saint Vincent Hospital, Worcester, MA 01608, USA. kitkungvan@hotmail.com
Insights
Many high-risk patients still don't meet low-density lipoprotein (LDL-C) targets. This study shows improving trends but highlights the need for more aggressive interventions in some high-risk individuals.
Area of Science:
- Cardiology
- Lipid Metabolism
- Preventive Medicine
Background:
- Despite advances, a significant number of patients fail to achieve recommended low-density lipoprotein cholesterol (LDL-C) targets.
- High-risk patients for coronary heart disease (CHD) require diligent lipid management to reduce cardiovascular events.
Purpose of the Study:
- To evaluate the success rate of achieving LDL-C goals in high-risk patients.
- To assess the trends in lipid goal attainment over a 12-month period.
Main Methods:
- Retrospective review of medical records for patients undergoing cardiac stress testing.
- Collection of demographic data, CHD risk factors, and lipid profiles.
- Reassessment of LDL-C levels at 12 months for patients not meeting initial targets.
Main Results:
- 62% of 765 high-risk CHD patients achieved an LDL-C goal < 100 mg/dL.
- In very high-risk patients (n=217), 83% achieved LDL-C < 100 mg/dL and 37% achieved < 70 mg/dL.
- At 12 months, 60% of reassessed patients reached LDL-C < 100 mg/dL, with a significant reduction in mean LDL-C (131 to 100 mg/dL) and increased antihyperlipidemic use (49% to 71%).
Conclusions:
- An improving trend in lipid goal attainment is observed in high- and very high-risk CHD patients.
- Despite improvements, a subset of these patients may necessitate more intensive therapeutic strategies.
- Continued monitoring and optimization of lipid-lowering therapies are crucial for high-risk populations.
Objectives:
Although improvement in target lipid achievement has been observed in recent studies, a significant proportion of patients still do not reach their recommended low-density lipoprotein (LDL-C) targets. We conducted a study in high-risk patients to evaluate the success rate in attaining LDL-C goals.
Methods:
Medical records of patients referred for cardiac stress testing were reviewed. Demographic data, coronary heart disease (CHD) risk factors, and the most recent lipid profile were recorded. The patients who did not achieve LDL-C target on initial evaluation were reassessed in 12 months.
Results:
A total of 765 patients were classified as high-risk CHD. The average age was 66 ± 12 years; 62% were men, and 29% had a previous history of CHD. The mean LDL-C was 96 ± 35 mg/dL and the LDL-C goal of less than 100 mg/dL was achieved in 62%. In 217 patients with very high CHD risk, 83% had LDL-C less than 100 mg/dL and 37% had LDL-C less than 70 mg/dL. At month 12, data from 267 patients were reviewed, and 161 patients (60%) reached LDL-C less than 100 mg/dL. The mean LDL-C was 131 ± 27 mg/dL and 100 ± 29 mg/dL (P < .001) at month 0 and 12, respectively. Antihyperlipidemics were initially prescribed in 49% of these patients and 71% at month 12 (P < .001).
Conclusion:
Our study confirms an improving trend in lipid goal attainment in high and very high CHD-risk patients, but despite this, certain high- and very high-risk patients may require more aggressive intervention.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
